Anna Protopapas
2022
Compensation breakdown
| Non-Equity Incentive Plan | $435,600 |
|---|---|
| Option Awards | $1,377,747 |
| Salary | $605,000 |
| Stock Awards | $420,760 |
| Other | $7,000 |
| Total | $2,846,107 |
Protopapas received $1.4M in option awards, accounting for 48% of the total pay in 2022.
Protopapas also received $435.6K in non-equity incentive plan, $605K in salary, $420.8K in stock awards and $7K in other compensation.
Rankings
In 2022, Anna Protopapas' compensation ranked 1,276th out of 5,753 executives tracked by ExecPay. In other words, Protopapas earned more than 77.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,276 out of 5,753 | 78th |
Division Manufacturing | 629 out of 3,133 | 80th |
Major group Chemicals And Allied Products | 233 out of 1,419 | 84th |
Industry group Drugs | 212 out of 1,320 | 84th |
Industry Pharmaceutical Preparations | 153 out of 966 | 84th |
Pay ratio
| Anna Protopapas' Pay | $2,846,107 |
|---|---|
| Median Employee's Pay | $243,051 |
| Pay Ratio | 12to 1 |
In 2022, the annual total compensation of Anna Protopapas was $2,846,107.
The annual total compensation of the median employee at Mersana Therapeutics was $243,051.
The ratio of Anna Protopapas' pay to the pay of median employee was therefore 12 to one.
Protopapas' colleagues
We found four more compensation records of executives who worked with Anna Protopapas at Mersana Therapeutics in 2022.
News
April 26, 2024
April 28, 2023
April 29, 2022
April 27, 2021
April 20, 2020
April 23, 2019